The Environmental Protection Agency (EPA) announced on April 5 that existing stocks of spirotetramat, the active ingredient in Movento™, Ultor™ and Kontos™ insecticides, may continue to be distributed and used within the normal channels of trade.

EPA acknowledged that the registrations had been cancelled "because of judicial action related to a procedural failure on the part of the Agency," and not because of any risk concerns associated with the product. Based on its review of hundreds of scientific studies, and after considering public comments submitted concerning existing stocks, EPA reconfirmed its conclusion that there are "no significant risk concerns associated with spirotetramat." In fact, EPA concluded that "spirotetramat has a more favorable risk profile in terms of human health and the environment than the registered alternatives."

Furthermore, EPA rejected recent suggestions by the Natural Resources Defense Council that spirotetramat use might pose a threat to honey bees, finding such claims unsupported by scientific data.The Agency’s favorable assessment of spirotetramat was based on numerous studies of its safety to honey bees and other important pollinators.

EPA noted that nearly 90% of the public comments received in response to the Agency’s solicitation of public input requested the continued use and distribution of existing stocks of spirotetramat. 

             ***********************************************
The BEE-L mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software.  For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

Access BEE-L directly at:
http://community.lsoft.com/scripts/wa-LSOFTDONATIONS.exe?A0=BEE-L